University Lyon 1, Louis Pradel hospital, Lyon. FranceService de pneumologie, hôpital Louis Pradel
Welcome,         Profile    Billing    Logout  
 14 Trials 
18 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cottin, Vincent
NCT03939520 / 2019-004326-19: Management of Progressive Disease in Idiopathic Pulmonary Fibrosis

Recruiting
4
378
Europe
pirfenidone and nintedanib, pirfenidone or nintedanib
Hospices Civils de Lyon, Ministry of Health
Progressive Idiopathic Pulmonary Fibrosis
01/26
01/26
NCT03626688 / 2018-001187-33: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Recruiting
3
1000
Europe, Canada, US, RoW
Ralinepag, APD811, Placebo
United Therapeutics
PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease
12/25
12/25
IMPALA-2, NCT04544293 / 2020-001263-85: Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Active, not recruiting
3
160
Europe, Canada, Japan, US, RoW
Molgramostim, Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF), Placebo
Savara Inc., Savara ApS,
Autoimmune Pulmonary Alveolar Proteinosis
11/23
11/24
TETON-2, NCT05255991 / 2021-005881-17: Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Active, not recruiting
3
597
Europe, RoW
Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer
United Therapeutics
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
07/25
07/25
EXAFIP2, NCT05674994: Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Recruiting
3
110
Europe
Methylprednisone/Prednisone, Placebo
Fondation Hôpital Saint-Joseph
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
10/25
12/26
IMPAHCT, NCT05036135 / 2021-001910-13: A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Terminated
2/3
202
Europe, Canada, US, RoW
AV-101, Placebo
Aerovate Therapeutics, Aerovate Therapeutics, Inc.
Pulmonary Arterial Hypertension
08/24
08/24
ELEVATE 2, NCT04712669 / 2020-004971-42: A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension

Completed
2
108
Europe, Canada, US, RoW
rodatristat ethyl 300 mg tablet BID, rodatristat ethyl 600 mg BID, Placebo
Altavant Sciences GmbH
Pulmonary Arterial Hypertension
06/23
08/23
RaDiCo PID, NCT04238871: Cohort (RaDiCo-ILD Cohort in English)

Recruiting
N/A
2500
Europe
Institut National de la Santé Et de la Recherche Médicale, France
Idiopathic Interstitial Pneumopathy/Pneumopathy Interstitial Diffuse, Paediatric and Adult Patients
03/21
09/21
HPI-COVID-19, NCT04376476: Host-pathogen Interactions During SARS-CoV-2 Infection

Completed
N/A
140
Europe
Blood sample, Low or upper respiratory tract sample, Stool collection or fecal swab, phone call
Hospices Civils de Lyon
Infection, Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2
05/22
05/22
I-FILE, NCT04304898: An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology

Recruiting
N/A
700
Europe
Home spirometry
Erasmus Medical Center
Pulmonary Fibrosis
07/25
07/26
RE-LAM-CE, NCT01484236: National Lymphangioleiomyomatosis Registry, France

Recruiting
N/A
200
Europe
Vincent COTTIN, Hospices Civils de Lyon
Lymphangioleiomyomatosis
12/24
12/25
HEMA-HTP, NCT02800941: Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension

Completed
N/A
203
Europe
Oral anticoagulant treatment, warfarin (Coumadine®), fluindione (Préviscan®), acenocoumarol (Sintrom®)
Centre Hospitalier Universitaire de Saint Etienne
Pulmonary Arterial Hypertension
09/22
09/23
ILDnose, NCT04680832: Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

Recruiting
N/A
600
Europe
Electronic nose, SpiroNose, eNose
Erasmus Medical Center
Pulmonary Fibrosis
12/25
12/26
FONCE-HTAP, NCT02579954: Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension

Completed
N/A
49
Europe
Rehabilitation, Supervised rehabilitation
Centre Hospitalier Universitaire de Saint Etienne, Ministry of Health, France
Pulmonary Arterial Hypertension
12/22
01/24
MAINEPSAN, NCT03290456 / 2018-001215-69: Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.

Recruiting
N/A
146
Europe
Prednisone 5mg/day extended of 12 additional months, Placebo 5mg/day extended of 12 additionnal months.
Hospices Civils de Lyon, Ministry of health
Granulomatosis With Polyangitis
06/24
06/24
MEDICO-LIBS, NCT03901196: Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)

Completed
N/A
86
Europe
Elemental analysis
University Hospital, Grenoble
Interstitial Lung Disease, Sarcoidosis, Idiopathic Pulmonary Fibrosis
04/24
04/24
DCP, NCT05951478: (RaDiCo Cohort) (RaDiCo-)

Recruiting
N/A
300
Europe
Institut National de la Santé Et de la Recherche Médicale, France
Primary Ciliary Dyskinesia
12/28
12/28
RaDiCo-ILD 2, NCT06036719: Interstitial Lung Disease: a Study from Infancy to Elderly Including Relatives

Recruiting
N/A
3000
Europe
Institut National de la Santé Et de la Recherche Médicale, France
Interstitial Lung Diseases
03/31
03/31
Cottin, V
No trials found
Renzoni, E
No trials found

Download Options